Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Lee's gets Asian rights to Windtree's KL4 surfactant products

Executive Summary

Windtree Therapeutics Inc. licensed Lee's Pharmaceutical Holdings Ltd. exclusive rights (including sublicensing rights) to develop and commercialize its KL4 surfactant products for respiratory distress syndrome (RDS) in China, Hong Kong, Thailand, Taiwan, and 12 other Asian territories.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register